# EDGAR Filing Document

**Accession Number:** 0001697013
**File Stem:** 0001214659-25-013029
**Filing Date:** 2025-8
**Character Count:** 35021
**Document Hash:** 3aaa2a10758f8662fb29212a14aec7f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001214659-25-013029.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001214659-25-013029

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eversept Partners, LP
- **CENTRAL INDEX KEY:** 0001697013

**ORGANIZATION NAME:**
- **EIN:** 475115829
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-18369
- **FILM NUMBER:** 251276971

**BUSINESS ADDRESS:**
- **STREET 1:** 444 MADISON AVENUE
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-271-4200

**MAIL ADDRESS:**
- **STREET 1:** 444 MADISON AVENUE
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Eversept Partners, L.P.
- **DATE OF NAME CHANGE:** 20180628

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Eversept Partners, LLC
- **DATE OF NAME CHANGE:** 20170202

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001697013

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Eversept Partners, LP

**Address:** 444 MADISON AVENUE, NEW YORK, NY 10022

**Telephone number:** 212-271-4200

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-18369

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 5493001KJTIIGC8Y1R12

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                                    | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                           | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Immunovant, Inc.                                  | 45258J102 | 08/12/2024     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          82013 |                0 | For         |                                    82013 | FOR                         |  |
| Affimed NV                                        | N01045207 | 10/10/2024     | Approve Remuneration Policy                                                | SECTION 14A SAY-ON-PAY VOTES |         166460 |                0 | For         |                                   166460 | FOR                         |  |
| Bio-Techne Corporation                            | 09073M104 | 10/24/2024     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         286312 |                0 | For         |                                   286312 | FOR                         |  |
| Viatris Inc.                                      | 92556V106 | 12/06/2024     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        1182606 |                0 | Against     |                                  1182606 | AGAINST                     |  |
| Viatris Inc.                                      | 92556V106 | 12/06/2024     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |        1182606 |                0 | For         |                                  1182606 | FOR                         |  |
| H. Lundbeck A/S                                   | K4406L137 | 03/26/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         537291 |                0 | For         |                                   537291 | FOR                         |  |
| H. Lundbeck A/S                                   | K4406L137 | 03/26/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |         537291 |                0 | For         |                                   537291 | FOR                         |  |
| H. Lundbeck A/S                                   | K4406L137 | 03/26/2025     | Approve Remuneration Policy                                                | SECTION 14A SAY-ON-PAY VOTES |         537291 |                0 | For         |                                   537291 | FOR                         |  |
| Humana Inc.                                       | 444859102 | 04/17/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          30777 |                0 | For         |                                    30777 | FOR                         |  |
| Revvity, Inc.                                     | 714046109 | 04/22/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         371990 |                0 | For         |                                   371990 | FOR                         |  |
| Galderma Group AG                                 | H3301B107 | 04/23/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         289092 |                0 | Against     |                                   289092 | AGAINST                     |  |
| Galderma Group AG                                 | H3301B107 | 04/23/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |         289092 |                0 | For         |                                   289092 | FOR                         |  |
| Galderma Group AG                                 | H3301B107 | 04/23/2025     | Approve Remuneration of Executive Directors and/or Non-Executive Directors | SECTION 14A SAY-ON-PAY VOTES |         289092 |                0 | Against     |                                   289092 | AGAINST                     |  |
| HCA Healthcare, Inc.                              | 40412C101 | 04/24/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         180786 |                0 | For         |                                   180786 | FOR                         |  |
| HCA Healthcare, Inc.                              | 40412C101 | 04/24/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         180786 |                0 | For         |                                   180786 | FOR                         |  |
| HCA Healthcare, Inc.                              | 40412C101 | 04/24/2025     | Submit Severance Agreement to Shareholder Vote                             | SECTION 14A SAY-ON-PAY VOTES |         180786 |                0 | Against     |                                   180786 | FOR                         |  |
| JPMorgan Liquidity Funds - USD Treasury CNAV Fund | L5780G536 | 04/25/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |          58466 |                0 | For         |                                    58466 | FOR                         |  |
| Molina Healthcare, Inc.                           | 60855R100 | 04/30/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          23717 |                0 | For         |                                    23717 | FOR                         |  |
| Molina Healthcare, Inc.                           | 60855R100 | 04/30/2025     | Approve Omnibus Stock Plan                                                 | SECTION 14A SAY-ON-PAY VOTES |          23717 |                0 | For         |                                    23717 | FOR                         |  |
| Inspire Medical Systems, Inc.                     | 457730109 | 05/01/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         160893 |                0 | For         |                                   160893 | FOR                         |  |
| GSK Plc                                           | G3910J179 | 05/07/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        2922625 |                0 | For         |                                  2922625 | FOR                         |  |
| GSK Plc                                           | G3910J179 | 05/07/2025     | Approve Remuneration Policy                                                | SECTION 14A SAY-ON-PAY VOTES |        2922625 |                0 | For         |                                  2922625 | FOR                         |  |
| GSK Plc                                           | G3910J179 | 05/07/2025     | Approve Restricted Stock Plan                                              | SECTION 14A SAY-ON-PAY VOTES |        2922625 |                0 | For         |                                  2922625 | FOR                         |  |
| ZimVie Inc.                                       | 98888T107 | 05/07/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        2079380 |                0 | For         |                                  2079380 | FOR                         |  |
| Avantor, Inc.                                     | 05352A100 | 05/08/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         122823 |                0 | Abstain     |                                   122823 | NONE                        |  |
| Teleflex Incorporated                             | 879369106 | 05/09/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          56630 |                0 | Abstain     |                                    56630 | NONE                        |  |
| Amarin Corporation Plc                            | 023111404 | 05/13/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        3399204 |                0 | Abstain     |                                  3399204 | NONE                        |  |
| Centene Corporation                               | 15135B101 | 05/13/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         428184 |                0 | For         |                                   428184 | FOR                         |  |
| Centene Corporation                               | 15135B101 | 05/13/2025     | Approve Omnibus Stock Plan                                                 | SECTION 14A SAY-ON-PAY VOTES |         428184 |                0 | For         |                                   428184 | FOR                         |  |
| Community Health Systems, Inc.                    | 203668108 | 05/13/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        8258433 |                0 | For         |                                  8258433 | FOR                         |  |
| Community Health Systems, Inc.                    | 203668108 | 05/13/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |        8258433 |                0 | For         |                                  8258433 | FOR                         |  |
| Elevance Health, Inc.                             | 036752103 | 05/14/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          23455 |                0 | For         |                                    23455 | FOR                         |  |
| MannKind Corporation                              | 56400P706 | 05/14/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         930275 |                0 | For         |                                   930275 | FOR                         |  |
| Syndax Pharmaceuticals, Inc.                      | 87164F105 | 05/14/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        4212270 |                0 | For         |                                  4212270 | FOR                         |  |
| Vera Therapeutics, Inc.                           | 92337R101 | 05/14/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        1864713 |                0 | For         |                                  1864713 | FOR                         |  |
| Vera Therapeutics, Inc.                           | 92337R101 | 05/14/2025     | Advisory Vote on Say on Pay Frequency                                      | SECTION 14A SAY-ON-PAY VOTES |        1864713 |                0 | One Year    |                                  1864713 | FOR                         |  |
| Repligen Corporation                              | 759916109 | 05/15/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          18452 |                0 | For         |                                    18452 | FOR                         |  |
| Travere Therapeutics, Inc.                        | 89422G107 | 05/15/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         867554 |                0 | For         |                                   867554 | FOR                         |  |
| Travere Therapeutics, Inc.                        | 89422G107 | 05/15/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         867554 |                0 | For         |                                   867554 | FOR                         |  |
| Align Technology, Inc.                            | 016255101 | 05/21/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          57420 |                0 | Abstain     |                                    57420 | NONE                        |  |
| Align Technology, Inc.                            | 016255101 | 05/21/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |          57420 |                0 | Abstain     |                                    57420 | NONE                        |  |
| Merus N.V.                                        | N5749R100 | 05/21/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          75136 |                0 | For         |                                    75136 | FOR                         |  |
| Neurocrine Biosciences, Inc.                      | 64125C109 | 05/21/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         167243 |                0 | Abstain     |                                   167243 | NONE                        |  |
| Neurocrine Biosciences, Inc.                      | 64125C109 | 05/21/2025     | Approve Omnibus Stock Plan                                                 | SECTION 14A SAY-ON-PAY VOTES |         167243 |                0 | Abstain     |                                   167243 | NONE                        |  |
| Neurocrine Biosciences, Inc.                      | 64125C109 | 05/21/2025     | Amend Qualified Employee Stock Purchase Plan                               | SECTION 14A SAY-ON-PAY VOTES |         167243 |                0 | Abstain     |                                   167243 | NONE                        |  |
| Maravai Lifesciences Holdings, Inc.               | 56600D107 | 05/22/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         942454 |                0 | Abstain     |                                   942454 | NONE                        |  |
| 89bio, Inc.                                       | 282559103 | 05/28/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         245298 |                0 | For         |                                   245298 | FOR                         |  |
| Karyopharm Therapeutics Inc.                      | 48576U205 | 05/28/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         257154 |                0 | Abstain     |                                   257154 | NONE                        |  |
| Karyopharm Therapeutics Inc.                      | 48576U205 | 05/28/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         257154 |                0 | Abstain     |                                   257154 | NONE                        |  |
| Karyopharm Therapeutics Inc.                      | 48576U205 | 05/28/2025     | Advisory Vote on Say on Pay Frequency                                      | SECTION 14A SAY-ON-PAY VOTES |         257154 |                0 | One Year    |                                   257154 | FOR                         |  |
| XOMA Royalty Corporation                          | 98419J206 | 05/28/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |          45017 |                0 | Against     |                                    45017 | AGAINST                     |  |
| Bruker Corporation                                | 116794108 | 05/29/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         475652 |                0 | For         |                                   475652 | FOR                         |  |
| Bruker Corporation                                | 116794108 | 05/29/2025     | Approve Omnibus Stock Plan                                                 | SECTION 14A SAY-ON-PAY VOTES |         475652 |                0 | For         |                                   475652 | FOR                         |  |
| Glaukos Corporation                               | 377322102 | 05/29/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         120340 |                0 | For         |                                   120340 | FOR                         |  |
| Globus Medical, Inc.                              | 379577208 | 06/04/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         183385 |                0 | For         |                                   183385 | FOR                         |  |
| Globus Medical, Inc.                              | 379577208 | 06/04/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         183385 |                0 | For         |                                   183385 | FOR                         |  |
| Globus Medical, Inc.                              | 379577208 | 06/04/2025     | Advisory Vote on Say on Pay Frequency                                      | SECTION 14A SAY-ON-PAY VOTES |         183385 |                0 | One Year    |                                   183385 | FOR                         |  |
| NewAmsterdam Pharma Company N.V.                  | N62509109 | 06/04/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         398223 |                0 | For         |                                   398223 | FOR                         |  |
| NewAmsterdam Pharma Company N.V.                  | N62509109 | 06/04/2025     | Advisory Vote on Say on Pay Frequency                                      | SECTION 14A SAY-ON-PAY VOTES |         398223 |                0 | One Year    |                                   398223 | FOR                         |  |
| Celldex Therapeutics, Inc.                        | 15117B202 | 06/05/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         696499 |                0 | For         |                                   696499 | FOR                         |  |
| Celldex Therapeutics, Inc.                        | 15117B202 | 06/05/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         696499 |                0 | For         |                                   696499 | FOR                         |  |
| Ionis Pharmaceuticals, Inc.                       | 462222100 | 06/05/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         426630 |                0 | For         |                                   426630 | FOR                         |  |
| Ionis Pharmaceuticals, Inc.                       | 462222100 | 06/05/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         426630 |                0 | For         |                                   426630 | FOR                         |  |
| Teva Pharmaceutical Industries Limited            | M8769Q102 | 06/05/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        2182158 |                0 | For         |                                  2182158 | FOR                         |  |
| Teva Pharmaceutical Industries Limited            | M8769Q102 | 06/05/2025     | Approve Remuneration Policy                                                | SECTION 14A SAY-ON-PAY VOTES |        2182158 |                0 | For         |                                  2182158 | FOR                         |  |
| Teva Pharmaceutical Industries Limited            | M8769Q102 | 06/05/2025     | Approve/Amend Employment Agreements                                        | SECTION 14A SAY-ON-PAY VOTES |        2182158 |                0 | For         |                                  2182158 | FOR                         |  |
| Teva Pharmaceutical Industries Limited            | M8769Q102 | 06/05/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |        2182158 |                0 | For         |                                  2182158 | FOR                         |  |
| Teva Pharmaceutical Industries Limited            | M8769Q102 | 06/05/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |        2182158 |                0 | For         |                                  2182158 | FOR                         |  |
| Sutro Biopharma, Inc.                             | 869367102 | 06/06/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        2292261 |                0 | For         |                                  2292261 | FOR                         |  |
| Fortrea Holdings Inc.                             | 34965K107 | 06/10/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         219384 |                0 | For         |                                   219384 | FOR                         |  |
| Fortrea Holdings Inc.                             | 34965K107 | 06/10/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         219384 |                0 | For         |                                   219384 | FOR                         |  |
| Alector, Inc.                                     | 014442107 | 06/11/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         605108 |                0 | For         |                                   605108 | FOR                         |  |
| Puma Biotechnology, Inc.                          | 74587V107 | 06/11/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         275788 |                0 | For         |                                   275788 | FOR                         |  |
| BioCryst Pharmaceuticals, Inc.                    | 09058V103 | 06/12/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        2101952 |                0 | For         |                                  2101952 | FOR                         |  |
| BioCryst Pharmaceuticals, Inc.                    | 09058V103 | 06/12/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |        2101952 |                0 | Against     |                                  2101952 | AGAINST                     |  |
| Natera, Inc.                                      | 632307104 | 06/12/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         815845 |                0 | For         |                                   815845 | FOR                         |  |
| Natera, Inc.                                      | 632307104 | 06/12/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         815845 |                0 | For         |                                   815845 | FOR                         |  |
| Vaxcyte, Inc.                                     | 92243G108 | 06/12/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         617243 |                0 | For         |                                   617243 | FOR                         |  |
| Liquidia Corporation                              | 53635D202 | 06/17/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         105914 |                0 | For         |                                   105914 | FOR                         |  |
| eHealth, Inc.                                     | 28238P109 | 06/18/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |          69357 |                0 | For         |                                    69357 | FOR                         |  |
| eHealth, Inc.                                     | 28238P109 | 06/18/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |          69357 |                0 | Against     |                                    69357 | AGAINST                     |  |
| AC Immune SA                                      | H00263105 | 06/19/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         100752 |                0 | For         |                                   100752 | FOR                         |  |
| AC Immune SA                                      | H00263105 | 06/19/2025     | Approve Remuneration of Directors and/or Committee Members                 | SECTION 14A SAY-ON-PAY VOTES |         100752 |                0 | Abstain     |                                   100752 | NONE                        |  |
| AC Immune SA                                      | H00263105 | 06/19/2025     | Approve Remuneration of Executive Directors and/or Non-Executive Directors | SECTION 14A SAY-ON-PAY VOTES |         100752 |                0 | For         |                                   100752 | FOR                         |  |
| AC Immune SA                                      | H00263105 | 06/19/2025     | Approve Qualified Employee Stock Purchase Plan                             | SECTION 14A SAY-ON-PAY VOTES |         100752 |                0 | For         |                                   100752 | FOR                         |  |
| Protagonist Therapeutics, Inc.                    | 74366E102 | 06/20/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         669798 |                0 | For         |                                   669798 | FOR                         |  |
| Viridian Therapeutics, Inc.                       | 92790C104 | 06/20/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        1586421 |                0 | For         |                                  1586421 | FOR                         |  |
| Viridian Therapeutics, Inc.                       | 92790C104 | 06/20/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |        1586421 |                0 | Abstain     |                                  1586421 | NONE                        |  |
| Viridian Therapeutics, Inc.                       | 92790C104 | 06/20/2025     | Approve Qualified Employee Stock Purchase Plan                             | SECTION 14A SAY-ON-PAY VOTES |        1586421 |                0 | For         |                                  1586421 | FOR                         |  |
| Gossamer Bio, Inc.                                | 38341P102 | 06/25/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |        3423546 |                0 | Do Not Vote |                                  3423546 | NONE                        |  |
| Gossamer Bio, Inc.                                | 38341P102 | 06/25/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |        3423546 |                0 | Do Not Vote |                                  3423546 | NONE                        |  |
| Teijin Ltd.                                       | J82270117 | 06/25/2025     | Approve Increase in Aggregate Compensation Ceiling for Directors           | SECTION 14A SAY-ON-PAY VOTES |         485900 |                0 | For         |                                   485900 | FOR                         |  |
| Teijin Ltd.                                       | J82270117 | 06/25/2025     | Approve Increase in Aggregate Compensation Ceiling for Statutory Auditors  | SECTION 14A SAY-ON-PAY VOTES |         485900 |                0 | For         |                                   485900 | FOR                         |  |
| Teijin Ltd.                                       | J82270117 | 06/25/2025     | Approve/Amend Bundled Remuneration Plans                                   | SECTION 14A SAY-ON-PAY VOTES |         485900 |                0 | For         |                                   485900 | FOR                         |  |
| Autolus Therapeutics Plc                          | 05280R100 | 06/26/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         557814 |                0 | For         |                                   557814 | FOR                         |  |
| Autolus Therapeutics Plc                          | 05280R100 | 06/26/2025     | Approve Remuneration Policy                                                | SECTION 14A SAY-ON-PAY VOTES |         557814 |                0 | For         |                                   557814 | FOR                         |  |
| Autolus Therapeutics Plc                          | 05280R100 | 06/26/2025     | Approve Qualified Employee Stock Purchase Plan                             | SECTION 14A SAY-ON-PAY VOTES |         557814 |                0 | For         |                                   557814 | FOR                         |  |
| HealthEquity, Inc.                                | 42226A107 | 06/26/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         368424 |                0 | For         |                                   368424 | FOR                         |  |
| United Therapeutics Corporation                   | 91307C102 | 06/26/2025     | Advisory Vote to Ratify Named Executive Officers' Compensation             | SECTION 14A SAY-ON-PAY VOTES |         130366 |                0 | For         |                                   130366 | FOR                         |  |
| United Therapeutics Corporation                   | 91307C102 | 06/26/2025     | Amend Omnibus Stock Plan                                                   | SECTION 14A SAY-ON-PAY VOTES |         130366 |                0 | For         |                                   130366 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Eversept Partners, LP

**By (Signature):** /s/ Ron Rosenstraus

**By (Printed Signature):** /s/ Ron Rosenstraus

**By (Title):** Chief Financial Officer

**Date:** 08/12/2025